Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Pinzani

Showing results (111-120 of 216) with videos related to

Pageof 22
Sort By:
Journal of Hepatology|December 15, 2015
Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertensionRajiv Jalan, Francesco De Chiara, Vairappan Balasubramaniyan, et al.
European Journal of Clinical Investigation|January 18, 2022
Assessment of clinically significant portal hypertension by two-dimensional shear wave elastographyIvica Grgurevic, Anita Madir, Vladimir Trkulja, et al.
European Journal of Clinical Investigation|February 15, 2019
Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitisFrancesca Saffioti, Davide Roccarina, Mette Vesterhus, et al.
Antiviral Therapy|November 3, 2010
Liver stiffness, a non-invasive marker of liver disease: a core study group reportFerruccio Bonino, Umberto Arena, Maurizia R Brunetto, et al.
Scientific Reports|July 27, 2025
Circulating biomarkers in patients with progressive fibrosing interstitial lung disease treated with nintedanib: a pilot studyVitale Miceli, Adriana Callari, Elisa Calzolari, et al.
Hepatology (Baltimore, Md.)|January 13, 2018
MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activationKatrin Böttcher, Krista Rombouts, Francesca Saffioti, et al.
Hepatology (Baltimore, Md.)|August 29, 2002
Cell adhesion regulates platelet-derived growth factor-induced MAP kinase and PI-3 kinase activation in stellate cellsVinicio Carloni, Raffaella M S Defranco, Alessandra Caligiuri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2019
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver diseaseElena Buzzetti, Salvatore Petta, Roberta Manuguerra, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 30, 2010
Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver diseaseValerio Nobili, Anna Alisi, Giuliano Torre, et al.
Cancers|October 13, 2021
Optimization and Validation of a Novel Three-Dimensional Co-Culture System in Decellularized Human Liver Scaffold for the Study of Liver Fibrosis and CancerKessarin Thanapirom, Elisabetta Caon, Margarita Papatheodoridi, et al.
Pageof 22

Showing results (111-120 of 216) with videos related to

Sort By:
Pageof 22
Journal of Hepatology|December 15, 2015
Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertensionRajiv Jalan, Francesco De Chiara, Vairappan Balasubramaniyan, et al.
European Journal of Clinical Investigation|January 18, 2022
Assessment of clinically significant portal hypertension by two-dimensional shear wave elastographyIvica Grgurevic, Anita Madir, Vladimir Trkulja, et al.
European Journal of Clinical Investigation|February 15, 2019
Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitisFrancesca Saffioti, Davide Roccarina, Mette Vesterhus, et al.
Antiviral Therapy|November 3, 2010
Liver stiffness, a non-invasive marker of liver disease: a core study group reportFerruccio Bonino, Umberto Arena, Maurizia R Brunetto, et al.
Scientific Reports|July 27, 2025
Circulating biomarkers in patients with progressive fibrosing interstitial lung disease treated with nintedanib: a pilot studyVitale Miceli, Adriana Callari, Elisa Calzolari, et al.
Hepatology (Baltimore, Md.)|January 13, 2018
MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activationKatrin Böttcher, Krista Rombouts, Francesca Saffioti, et al.
Hepatology (Baltimore, Md.)|August 29, 2002
Cell adhesion regulates platelet-derived growth factor-induced MAP kinase and PI-3 kinase activation in stellate cellsVinicio Carloni, Raffaella M S Defranco, Alessandra Caligiuri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2019
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver diseaseElena Buzzetti, Salvatore Petta, Roberta Manuguerra, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 30, 2010
Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver diseaseValerio Nobili, Anna Alisi, Giuliano Torre, et al.
Cancers|October 13, 2021
Optimization and Validation of a Novel Three-Dimensional Co-Culture System in Decellularized Human Liver Scaffold for the Study of Liver Fibrosis and CancerKessarin Thanapirom, Elisabetta Caon, Margarita Papatheodoridi, et al.
Pageof 22